Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Positive phase III results obtained for Metformin GR in type 2 diabetes

Feb. 5, 2003

Vertex describes new protein kinase inhibitors

Feb. 5, 2003

Merck researchers describe novel PTP1B inhibitors for diabetes and metabolic disorders

Feb. 4, 2003

Novel PPAR agonists identified by Eisai scientists

Feb. 3, 2003

Encouraging results reported for SomatoKine in adolescent type 1 diabetics

Jan. 31, 2003

EDEMA1 trial for DX-88 in hereditary angioedema begins patient treatment

Jan. 31, 2003

Safety of ThGRF demonstrated in patients with type 2 diabetes

Jan. 31, 2003

Recent Tanabe Seiyaku patent covers novel inhibitors of apo B secretion

Jan. 31, 2003

New 5-HT6 antagonists with utility in obesity, NIDDM and CNS disorders

Jan. 31, 2003

Novel glucose- and lipid-lowering agents in early development at Kyoto Pharmaceutical

Jan. 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.